# Diag Capital Management, LP

> Institutional holdings reported to the SEC as of Q4 2018 on Form 13F. CIK 1687807. Source: https://holderbook.com/funds/1687807-diag-capital-management-lp/

- Reported value: $87.4M
- Positions: 40
- Weight of the ten largest: 50.2%
- Filed: 2019-02-14

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| BAXTER INTL INC | [BAX](https://holderbook.com/stocks/BAX/) | $5.7M | 85,933 | 6.5% | 1 |
| ATHENEX INC | [ATNX](https://holderbook.com/stocks/ATNX/) | $5.4M | 429,046 | 6.2% | 1 |
| ZIMMER BIOMET HOLDINGS INC | [ZBH](https://holderbook.com/stocks/ZBH/) | $4.9M | 47,684 | 5.7% | 1 |
| ABBVIE INC | [ABBV](https://holderbook.com/stocks/ABBV/) | $4.6M | 50,420 | 5.3% | 1 |
| INCYTE CORP | [INCY](https://holderbook.com/stocks/INCY/) | $4.6M | 72,196 | 5.3% | 1 |
| QUANTERIX CORP | [QTRX](https://holderbook.com/stocks/QTRX/) | $4.1M | 223,949 | 4.7% | 1 |
| CELGENE CORP | [CELG](https://holderbook.com/stocks/CELG/) | $4.0M | 63,159 | 4.6% | 1 |
| AMGEN INC | [AMGN](https://holderbook.com/stocks/AMGN/) | $3.9M | 20,110 | 4.5% | 1 |
| MEDTRONIC PLC | [MDT](https://holderbook.com/stocks/MDT/) | $3.3M | 36,180 | 3.8% | 1 |
| QUOTIENT LTD | [QTNT](https://holderbook.com/stocks/QTNT/) | $3.2M | 526,932 | 3.7% | 1 |
| PCRX 3.25 2/19 | - | $3.2M | 74,502 | 3.7% | 1 |
| TAKEDA PHARMACEUTICAL CO LTD | [TAK](https://holderbook.com/stocks/TAK/) | $3.0M | 177,260 | 3.4% | 1 |
| ABBOTT LABORATORIES | [ABT](https://holderbook.com/stocks/ABT/) | $2.8M | 38,585 | 3.2% | 1 |
| ZAI LAB LTD | [ZLAB](https://holderbook.com/stocks/ZLAB/) | $2.8M | 120,092 | 3.2% | 1 |
| MYLAN N V | [MYL](https://holderbook.com/stocks/MYL/) | $2.7M | 99,410 | 3.1% | 1 |
| POLARITYTE INC | [PTE](https://holderbook.com/stocks/PTE/) | $2.5M | 182,833 | 2.8% | 1 |
| VIEWRAY INC | [VRAYQ](https://holderbook.com/stocks/VRAYQ/) | $2.4M | 397,375 | 2.8% | 1 |
| REGENERON PHARMACEUTICALS | [REGN](https://holderbook.com/stocks/REGN/) | $2.2M | 5,792 | 2.5% | 1 |
| TEVA PHARMACEUTICAL INDS LTD | [TEVA](https://holderbook.com/stocks/TEVA/) | $2.2M | 139,531 | 2.5% | 1 |
| AKORN INC | [AKRXQ](https://holderbook.com/stocks/AKRXQ/) | $2.1M | 634,046 | 2.5% | 1 |
| HAEMONETICS CORP MASS | [HAE](https://holderbook.com/stocks/HAE/) | $2.1M | 21,220 | 2.4% | 1 |
| ARGENX SE | [ARGX](https://holderbook.com/stocks/ARGX/) | $1.6M | 16,712 | 1.8% | 1 |
| BIOHAVEN PHARMACTL HLDG CO L | [BHVNXXXX](https://holderbook.com/stocks/BHVNXXXX/) | $1.4M | 38,319 | 1.6% | 1 |
| MERIT MED SYS INC | [MMSI](https://holderbook.com/stocks/MMSI/) | $1.4M | 25,092 | 1.6% | 1 |
| SANOFI SA | [SNY](https://holderbook.com/stocks/SNY/) | $1.3M | 30,240 | 1.5% | 1 |
| GW PHARMACEUTICALS PLC | [GWPH](https://holderbook.com/stocks/GWPH/) | $1.3M | 13,460 | 1.5% | 1 |
| LIVANOVA PLC | [LIVN](https://holderbook.com/stocks/LIVN/) | $1.1M | 11,974 | 1.3% | 1 |
| MOLECULAR TEMPLATES INC | [MTEM](https://holderbook.com/stocks/MTEM/) | $985.0K | 243,839 | 1.1% | 1 |
| FOAMIX PHARMACEUTICALS LTD | [FOMX](https://holderbook.com/stocks/FOMX/) | $960.0K | 146,432 | 1.1% | 1 |
| VERRICA PHARMACEUTICALS INC | [VRCA](https://holderbook.com/stocks/VRCA/) | $937.0K | 114,947 | 1.1% | 1 |
| NEUROCRINE BIOSCIENCES INC | [NBIX](https://holderbook.com/stocks/NBIX/) | $876.0K | 12,266 | 1.0% | 1 |
| DENTSPLY SIRONA INC | [XRAY](https://holderbook.com/stocks/XRAY/) | $757.0K | 20,347 | 0.9% | 1 |
| AXONICS INC | [AXNX](https://holderbook.com/stocks/AXNX/) | $702.0K | 46,485 | 0.8% | 1 |
| ARYA SCIENCES ACQUISITION CO | [ARYAU](https://holderbook.com/stocks/ARYAU/) | $522.0K | 50,500 | 0.6% | 1 |
| ADMA BIOLOGICS INC | [ADMA](https://holderbook.com/stocks/ADMA/) | $435.0K | 182,100 | 0.5% | 1 |
| MADRIGAL PHARMACEUTICALS INC | [MDGL](https://holderbook.com/stocks/MDGL/) | $326.0K | 2,890 | 0.4% | 1 |
| ARVINAS INC | [ARVN](https://holderbook.com/stocks/ARVN/) | $311.0K | 24,210 | 0.4% | 1 |
| NOVAVAX INC | - | $286.0K | 155,320 | 0.3% | 1 |
| NEOS THERAPEUTICS INC | [NEOS](https://holderbook.com/stocks/NEOS/) | $278.0K | 168,642 | 0.3% | 1 |
| ANAPTYSBIO INC | [ANAB](https://holderbook.com/stocks/ANAB/) | $95.0K | 1,493 | 0.1% | 1 |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q4 2018 | $87.4M | 40 |